VVZ API is not affiliated with ETH Zurich. Data might be outdated or incorrect. Please view the official ETHZ Vorlesungsverzeichnis for binding information.

395-0206-00L 2 Credits NDS , WBZ D-HEST
You're viewing possible stale or outdated data. Please check the latest semester for more up-to-date information.

Approval Post Market Activities

VVZ CR n/a

Last Updated: 2026-02-05 16:37:05

Abstract

Exploring SaMD, MD, IVD, ATMPs, and Pharma regulations, we contrast their approval requirements and PMS strategies, focus-ing on safety, performance, and biological / chemical complexity. We look at reimbursement issues and link them to regulatory ap-proval and market access strategies, including economic aspects of product lifecycle management.

Objective

Principle of Regulatory Thinking • Apply the principle of regulatory thinking to navigate the healthtech product approval process. • Synthesize commonalities and differences in regulatory requirements across product types. Approval Processes • Outline the essential steps for pre-market approval, including clinical evaluation and testing. • Formulate strategies for effective regulatory submissions and agency interactions. Post-Market Surveillance (PMS) • Develop a framework for ongoing monitoring and reporting of product safety and effectiveness. • Prepare for adverse event reporting, recalls, and post-market clinical follow-up. Reimbursement Strategies • Link reimbursement strategies to regulatory approval and market access considerations. • Compare pricing and reimbursement models, understanding their influence on product success.

Content

Overview of Regulatory Frameworks for Healthtech Products • SaMD, MD, and IVD: Focus on safety and performance • ATMPs: Additional considerations for biological complexity • Pharmaceuticals: Distinct pathways based on chemical composition Principle of RegulatoryThinking • Commonalities in regulatory requirements across product types • Differences in approval processes for SaMD, MD, IVD, ATMPs vs. Pharmaceuticals Approval Processes • Regulatory submissions and interactions with agencies Post-Market Surveillance (PMS) • Reporting for ongoing safety and effectiveness • Adverse event reporting and product recalls • Post-market clinical follow-up and real-world evidence collection Reimbursement Strategies • Linking reimbursement to regulatory approval • Health economics and market access considerations • Pricing and reimbursement models for healthtech products Regulatory Compliance and Lifecycle Management • Maintaining compliance in a changing regulatory landscape • Managing product variations and updates • Role of quality management systems in regulatory compli-ance

General Information

Language
English
Levels
NDS , WBZ
Frequency
Yearly recurring

Examination

Type
ungraded semester performance

Registration & Places

Priority: Registration for the course unit is only possible for the primary target group

Course Components

Type Title Time & Place Hours
lecture with exercise Approval Post Market Activities
  • 24.05 Date 09:00-17:00 (ON LI NE)
  • 31.05 Date 09:00-17:00 (ON LI NE)
  • 07.06 Date 09:15-17:00 (HG E 42)
  • 14.06 Date 09:15-17:00 (HG F 26.1)
  • 21.06 Date 09:00-17:00 (ON LI NE)
25 h semesterly

Offered In